tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of David Risinger, 135 are a BUY (52.12%), 105 are a HOLD (40.54%), 19 are a SELL (7.34%).
Analyst David Risinger, currently employed at LEERINK, carries an average stock price target met ratio of 74.78% that have a potential upside of 19.93% achieved within 257 days.
David Risinger’s has documented 490 price targets and ratings displayed on 31 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on REGN, Regeneron Pharmaceuticals at 05-Feb-2025.
Analyst best performing recommendations are on BHC (BAUSCH HEALTH COMPANIES).
The best stock recommendation documented was for ALKS (ALKERMES PLC) at 1/21/2016. The price target of $35 was fulfilled within 1 day with a profit of $1.31 (3.89%) receiving and performance score of 38.88.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$214
$27.94 (15.02%)
$214
16 days ago
(17-Apr-2025)
23/25 (92%)
$41.01 (23.71%)
431
Buy
$241
$54.94 (29.53%)
$239
24 days ago
(09-Apr-2025)
12/17 (70.59%)
$61.16 (34.01%)
526
Buy
$240
$53.94 (28.99%)
$210
1 months 28 days ago
(05-Mar-2025)
7/8 (87.5%)
$28.46 (13.45%)
474
Hold
$223
$36.94 (19.85%)
$191
1 months 29 days ago
(04-Mar-2025)
3/4 (75%)
$15.71 (7.58%)
443
Buy
$217
$30.94 (16.63%)
$211
3 months ago
(03-Feb-2025)
2/3 (66.67%)
$26.86 (14.13%)
103
Which stock is David Risinger is most bullish on?
Which stock is David Risinger is most reserved on?
What Year was the first public recommendation made by David Risinger?
